Anti-MKRN3 monoclonal antibody

Pre-made anti-MKRN3 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to MKRN3/MKRN3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2600-Ab-1/ GM-Tg-hg-IP2600-Ab-2Anti-Human MKRN3 monoclonal antibodyHuman
GM-Tg-rg-IP2600-Ab-1/ GM-Tg-rg-IP2600-Ab-2Anti-Rat MKRN3 monoclonal antibodyRat
GM-Tg-mg-IP2600-Ab-1/ GM-Tg-mg-IP2600-Ab-2Anti-Mouse MKRN3 monoclonal antibodyMouse
GM-Tg-cynog-IP2600-Ab-1/ GM-Tg-cynog-IP2600-Ab-2Anti-Cynomolgus/ Rhesus macaque MKRN3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2600-Ab-1/ GM-Tg-felg-IP2600-Ab-2Anti-Feline MKRN3 monoclonal antibodyFeline
GM-Tg-cang-IP2600-Ab-1/ GM-Tg-cang-IP2600-Ab-2Anti-Canine MKRN3 monoclonal antibodyCanine
GM-Tg-bovg-IP2600-Ab-1/ GM-Tg-bovg-IP2600-Ab-2Anti-Bovine MKRN3 monoclonal antibodyBovine
GM-Tg-equg-IP2600-Ab-1/ GM-Tg-equg-IP2600-Ab-2Anti-Equine MKRN3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2600-Ab-1/ GM-Tg-hg-IP2600-Ab-2; GM-Tg-rg-IP2600-Ab-1/ GM-Tg-rg-IP2600-Ab-2;
GM-Tg-mg-IP2600-Ab-1/ GM-Tg-mg-IP2600-Ab-2; GM-Tg-cynog-IP2600-Ab-1/ GM-Tg-cynog-IP2600-Ab-2;
GM-Tg-felg-IP2600-Ab-1/ GM-Tg-felg-IP2600-Ab-2; GM-Tg-cang-IP2600-Ab-1/ GM-Tg-cang-IP2600-Ab-2;
GM-Tg-bovg-IP2600-Ab-1/ GM-Tg-bovg-IP2600-Ab-2; GM-Tg-equg-IP2600-Ab-1/ GM-Tg-equg-IP2600-Ab-2
Products NameAnti-MKRN3 monoclonal antibody
Formatmab
Target NameMKRN3
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-MKRN3 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2600-Ag-1Recombinant multi-species MKRN3/ CPPB2/ D15S9 protein


    Target information

    Target IDGM-IP2600
    Target NameMKRN3
    Gene ID7681,22652,292988,710776,102152441,101088413,517464,100060875
    Gene Symbol and SynonymsCPPB2,D15S9,D7H15S9-1,MKRN3,RNF63,ZFP127,ZNF127
    Uniprot AccessionQ13064
    Uniprot Entry NameMKRN3_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000179455
    Target ClassificationN/A

    The target: MKRN3, gene name: MKRN3, also named as CPPB2, D15S9, RNF63, ZFP127, ZNF127. The protein encoded by this gene contains a RING (C3HC4) zinc finger motif and several C3H zinc finger motifs. This gene is intronless and imprinted, with expression only from the paternal allele. Disruption of the imprinting at this locus may contribute to Prader-Willi syndrome. An antisense RNA of unknown function has been found overlapping this gene. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.